Children's National Medical Center
Also known as: AeRang Kim | Allistair Abraham, MD | Bennett Lavenstein | Children's National | Children's National Health System | Childrens National Health System | Children's National Health System, Department of Neurology | Children's National Hospital | Children's National Medical Center, Center for Genetic Medicine | Children's National Medical Center - Chairman of the NF Consortium | Children's National Medical Center, Children's Research Institute | Children's National Medical Center, Div. of Aldol & Young Adult Medicine | Children's National Medical Center-PPRU | Children's National Medical Center, San Diego, California | Children's National Medical Center, Washington | Children's National Medical Center, Washington, D.C. | Children's National, Washington DC | Childrens Natonal Medical Center | Children's Research Institute | Children's Research Institute, Children's National Medical Center | Children's Reserach Institute | CNMC | Director, Multi-Center Studies Section, Children's National Medical Center | Holly Meany, MD | Janelle Vaughns | Jeffrey Moak | Julia Finkel | Laura Tosi | Michael Keller | Nancy Bauman | Nicholas Ah Mew | Roger Packer | Srijaya K. Reddy, MD, MBA
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1995Last known activity
May 1, 2020
Timeline
1870s
- Jan 1, 1870
Children's National Medical Center— Founded
Drugs by trial phase (131 distinct, 105 trials)
Phase 4 (18 own, 0 via acquisition)
Phase 3 (43 own, 0 via acquisition)
Phase 2 (32 own, 0 via acquisition)
Phase 1 (29 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Acidosis
- Acute Chest Syndrome
- Adenoviridae Infections
- Amino Acid Metabolism, Inborn Errors
- Ancylostomiasis
- Anemia
- Anemia, Sickle Cell
- Arnold-Chiari Malformation
- Arrhythmias, Cardiac
- Asphyxia
- Asphyxia Neonatorum
- Asthma
- Attention Deficit Disorder with Hyperactivity
- beta-Thalassemia
- Biliary Atresia
- Brain Diseases
- Brain Edema
- Brain Ischemia
- Brain Neoplasms
- Bronchiolitis
- Bronchiolitis, Viral
- Carbamoyl-Phosphate Synthase I Deficiency Disease
- Central Nervous System Neoplasms
- Communicable Diseases
- Craniosynostoses
- Critical Illness
- Cytomegalovirus Infections
- Deficiency Diseases
- Disease
- Dwarfism
- Emergencies
- Epilepsy
- Epilepsy, Absence
- Epilepsy, Post-Traumatic
- Epstein-Barr Virus Infections
- Gangliosidoses
- Gangliosidoses, GM2
- Gastroenteritis
- Gastroesophageal Reflux
- Glioma
- Heart Defects, Congenital
- Heart Diseases
- Heart Septal Defects, Atrial
- Hemangioma
- Hematologic Diseases
- Hematologic Neoplasms
- Hemoglobinopathies
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hodgkin Disease
- Hookworm Infections
- Hyperalgesia
- Hyperammonemia
- Hypophosphatemia
- Hypothermia
- Hypoxia
- Hypoxia-Ischemia, Brain
- Infections
- Inflammatory Bowel Diseases
- Infratentorial Neoplasms
- Intestinal Diseases
- Leiomyosarcoma
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lower Urinary Tract Symptoms
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Lymphoproliferative Disorders
- Malaria
- Malaria, Cerebral
- Medulloblastoma
- Metabolism, Inborn Errors
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Nerve Sheath Neoplasms
- Nervous System Neoplasms
- Neuroblastoma
- Neurofibroma
- Neurofibroma, Plexiform
- Neurofibromatoses
- Neurofibromatosis 1
- Neurofibrosarcoma
- Nevus, Sebaceous of Jadassohn
- Obesity
- Ornithine Carbamoyltransferase Deficiency Disease
- Osteosarcoma
- Otitis
- Pediatric Obesity
- Postoperative Hemorrhage
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Premature Birth
- Propionic Acidemia
- Puberty, Precocious
Recent trials (50)
- NCT04219007Sponsor investigatorPhase 2May 1, 2020
- NCT04219007Lead sponsorPhase 2May 1, 2020
- NCT04200313OfficialN/AMar 31, 2020
- NCT04200313Overall official - principal investigatorN/AMar 31, 2020
- NCT04248192Overall official - principal investigatorPhase 1Mar 31, 2020
- NCT04236479Overall official - principal investigatorPhase 1Feb 29, 2020
- NCT04234906Lead sponsorPhase 4Jan 31, 2020
- NCT04240756CollaboratorPhase 3Jan 31, 2020
- NCT04234906Sponsor investigatorPhase 4Jan 31, 2020
- NCT04234906Overall official - principal investigatorPhase 4Jan 31, 2020
- NCT03993821Lead sponsorEarly Phase 1Aug 31, 2019
- NCT03993821CollaboratorEarly Phase 1Aug 31, 2019
- NCT03993821Overall official - principal investigatorEarly Phase 1Aug 31, 2019
- NCT03993821Sponsor investigatorEarly Phase 1Aug 31, 2019
- NCT03936894Reponsible party - principal investigatorPhase 1/Phase 2May 31, 2019
Details
- Founded
- Washington D.C., US Jan 1, 1870
- Last known activity
- May 1, 2020